Original Research

Published on 23 Sep 2024

Molecular profiling of pre- and post- 5-azacytidine myelodysplastic syndrome samples identifies predictors of response

in Hematologic Malignancies

Mónica del Rey González
Sohini Chakraborty
Jesús María Hernández-Sánchez
María Diez Campelo
Christopher Y. Park
Jesús María Hernández Rivas

Frontiers in Oncology

doi 10.3389/fonc.2024.1438052

747 views

Review

Published on 23 Sep 2024

Ferroptosis: a new mechanism of traditional Chinese medicine for treating hematologic malignancies

in Hematologic Malignancies

Xinyue Gou
Xudong Tang
Chi Liu
Zhuo Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1469178

698 views

Original Research

Published on 19 Sep 2024

Sorafenib maintenance after allogeneic stem cell transplantation in patients with FLT3+ AML receiving midostaurin during induction and consolidation: a retrospective analysis

in Hematologic Malignancies

Giuseppe Sapienza
Marta Castronovo
Stefania Tringali
Roberto Bono
Cristina Rotolo
Antonino Mulè
Valeria Calafiore
Caterina Patti
Cecilia Agueli
Valentina Randazzo

Frontiers in Oncology

doi 10.3389/fonc.2024.1441254

611 views

Case Report

Published on 16 Sep 2024

Case report: Combination therapy with selinexor, decitabine and half-dose CAG regimen for relapsed elderly acute myeloid leukemia

in Hematologic Malignancies

Xueya Zhang
Yuqi Sun
Jinfa Zhong

Frontiers in Oncology

doi 10.3389/fonc.2024.1391329

577 views

Review

Published on 13 Sep 2024

How we diagnose Myelodysplastic syndromes

in Hematologic Malignancies

Howard S. Oster
Moshe Mittelman

Frontiers in Oncology

doi 10.3389/fonc.2024.1415101

2,474 views

Review

Published on 10 Sep 2024

Management of infections for patient treated with ibrutinib in clinical practice

in Hematologic Malignancies

Claudia Baratè
Ilaria Scortechini
Sara Ciofini
Paola Picardi
Ilaria Angeletti
Federica Loscocco
Alessandro Sanna
Alessandro Isidori
Paolo Sportoletti

Frontiers in Oncology

doi 10.3389/fonc.2024.1428464

890 views

Case Report

Published on 09 Sep 2024

Case report: Development of clonal hematologic disorders from inherited bone marrow failure

in Hematologic Malignancies

Jaroslav Cermak

Frontiers in Oncology

doi 10.3389/fonc.2024.1420666

489 views

Original Research

Published on 05 Sep 2024

Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVD

in Hematologic Malignancies

Alessandro Cellini
Chiara Adele Cavarretta
Francesco Angotzi
Valeria Ruocco
Andrea Serafin
Nicolò Danesin
Marco Pizzi
Michele Gregianin
Stefania Vio
Filippo Crimì

Frontiers in Oncology

doi 10.3389/fonc.2024.1419118

514 views

Case Report

Published on 05 Sep 2024

Case report: NUP98::LEDGF fusion gene drives malignant hematological tumor with mixed immunological phenotype

in Hematologic Malignancies

Song Xue
Jia-qi Chen
Tong Wang
Li-na Zhang
Man Chen
Hui-peng Sun

Frontiers in Oncology

doi 10.3389/fonc.2024.1396655

615 views
1 citation

Case Report

Published on 04 Sep 2024

Case report: Successful therapy with azacitidine for acute myeloid leukemia with NUP98::RARG resembling acute promyelocytic leukemia

in Hematologic Malignancies

Zhichen Wei
Linlin Shao
Shuqian Xu
Xiaolin Zhang
Lin Wang
Ping Qin
Qiang Song
Ming Hou

Frontiers in Oncology

doi 10.3389/fonc.2024.1460557

767 views

Case Report

Published on 30 Aug 2024

Liver fibrosis among infants with t(1;22)(p13;q13) acute megakaryoblastic leukemia: a case report and literature review

in Hematologic Malignancies

Nira Arad-Cohen
Ori Attias
Yaniv Zohar
Yoav H. Messinger

Frontiers in Oncology

doi 10.3389/fonc.2024.1441318

485 views

Review

Published on 30 Aug 2024

Focal adhesion kinase as a new player in the biology of onco-hematological diseases: the starting evidence

in Hematologic Malignancies

Guido Capasso
Nayla Mouawad
Maria Castronuovo
Edoardo Ruggeri
Andrea Visentin
Livio Trentin
Federica Frezzato

Frontiers in Oncology

doi 10.3389/fonc.2024.1446723

829 views

Systematic Review

Published on 30 Aug 2024

Comparative efficacy and hematologic safety of different dosages of JAK inhibitors in the treatment of myelofibrosis: a network meta-analysis

in Hematologic Malignancies

Ke Chen
Yanyu Zhang
Jixuan Zou
Dehao Wang
Xinyue Yu
Yan Sun
Yumeng Li
Jicong Niu
Yi Chen
Pei Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1403967

1,071 views

Review

Published on 26 Aug 2024

Critical review of clinical data and expert-based recommendations for the use of bosutinib in the treatment of chronic myeloid leukemia

in Hematologic Malignancies

Valentín García-Gutiérrez
María Teresa Gómez-Casares
Blanca Xicoy
Felipe Casado-Montero
Guillermo Orti
Pilar Giraldo
Juan Carlos Hernández-Boluda

Frontiers in Oncology

doi 10.3389/fonc.2024.1405467

972 views

Original Research

Published on 21 Aug 2024

The impact of donor-specific antibodies’ presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center

in Hematologic Malignancies

Simona Sica
Elisabetta Metafuni
Filippo Frioni
Maria Assunta Limongiello
Eugenio Galli
Federica Sorà
Andrea Bacigalupo
Elvira Poggi
Mariano Antonio Feccia
Annarita Manfreda

Frontiers in Oncology

doi 10.3389/fonc.2024.1387181

584 views

Editorial

Published on 19 Aug 2024

Editorial: Efficacy and safety of CAR-T cell therapy in hematologic malignancies

in Hematologic Malignancies

Marcos de Lima
Alice Di Rocco
Jose-Maria Ribera

Frontiers in Oncology

doi 10.3389/fonc.2024.1472463

607 views

Navigation group

Articles

Molecular profiling of pre- and post- 5-azacytidine myelodysplastic syndrome samples identifies predictors of response

Ferroptosis: a new mechanism of traditional Chinese medicine for treating hematologic malignancies

Sorafenib maintenance after allogeneic stem cell transplantation in patients with FLT3+ AML receiving midostaurin during induction and consolidation: a retrospective analysis

Case report: Combination therapy with selinexor, decitabine and half-dose CAG regimen for relapsed elderly acute myeloid leukemia

How we diagnose Myelodysplastic syndromes

Management of infections for patient treated with ibrutinib in clinical practice

Case report: Development of clonal hematologic disorders from inherited bone marrow failure

Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVD

Case report: NUP98::LEDGF fusion gene drives malignant hematological tumor with mixed immunological phenotype

Case report: Successful therapy with azacitidine for acute myeloid leukemia with NUP98::RARG resembling acute promyelocytic leukemia

Liver fibrosis among infants with t(1;22)(p13;q13) acute megakaryoblastic leukemia: a case report and literature review

Focal adhesion kinase as a new player in the biology of onco-hematological diseases: the starting evidence

Comparative efficacy and hematologic safety of different dosages of JAK inhibitors in the treatment of myelofibrosis: a network meta-analysis

Critical review of clinical data and expert-based recommendations for the use of bosutinib in the treatment of chronic myeloid leukemia

The impact of donor-specific antibodies’ presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center

Editorial: Efficacy and safety of CAR-T cell therapy in hematologic malignancies